Literature DB >> 27098923

Effects of hyperthermia in neutralising mechanisms of drug resistance in non-muscle-invasive bladder cancer.

Antoine G van der Heijden1, Mark W Dewhirst2.   

Abstract

Non-muscle-invasive bladder cancer is a challenging disease, even given its superficial nature. It is prone to multiple recurrences and progression to muscle-invasive cancer. These features of this disease contribute significantly to reduced quality of life as well as creating significant morbidity and even mortality. Randomised trials demonstrate that when hyperthermia is added to conventional mitomycin-C treatment that local control rates and progression-free survival are substantially improved. In this review we consider how hyperthermia can exert such beneficial effects. Some of the mechanisms presented are theoretical, while others are facts. It is hoped that this review will contribute rationale for further examination of mechanisms, because an understanding of such mechanisms may lead to even better chemotherapeutic approaches, as well as potential biomarkers for predicting and monitoring treatment success.

Entities:  

Keywords:  Drug transport; hyperthermia; intravesical chemotherapy; non-muscle-invasive bladder cancer; thermochemotherapy

Mesh:

Substances:

Year:  2016        PMID: 27098923     DOI: 10.3109/02656736.2016.1155761

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  6 in total

Review 1.  Ultrasound Hyperthermia Technology for Radiosensitization.

Authors:  Lifei Zhu; Michael B Altman; Andrei Laszlo; William Straube; Imran Zoberi; Dennis E Hallahan; Hong Chen
Journal:  Ultrasound Med Biol       Date:  2019-02-14       Impact factor: 2.998

2.  Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study.

Authors:  Wei Phin Tan; Andrew Chang; Steven C Brousell; Dominic C Grimberg; Joseph J Fantony; Thomas A Longo; Wiguins Etienne; Ivan Spasojevic; Paolo Maccarini; Brant A Inman
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

3.  Solid Magnetoliposomes as Multi-Stimuli-Responsive Systems for Controlled Release of Doxorubicin: Assessment of Lipid Formulations.

Authors:  Beatriz D Cardoso; Vanessa F Cardoso; Senetxu Lanceros-Méndez; Elisabete M S Castanheira
Journal:  Biomedicines       Date:  2022-05-23

4.  Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder.

Authors:  Nathalie van den Tempel; Kishan A T Naipal; Anja Raams; Dik C van Gent; Martine Franckena; Joost L Boormans; Roland Kanaar
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

5.  A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer.

Authors:  J W Van Hattum; E M Scutigliani; R F C P A Helderman; R Zweije; H M Rodermond; A L Oei; J Crezee; J R Oddens; T M De Reijke; P M Krawczyk
Journal:  Sci Rep       Date:  2022-04-29       Impact factor: 4.996

Review 6.  Impact of Effective Intravesical Therapies on Quality of Life in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review.

Authors:  John W Yuen; Ricky W Wu; Shirley S Ching; Chi-Fai Ng
Journal:  Int J Environ Res Public Health       Date:  2022-08-30       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.